99mTc-Human serum albumin: An effective radiotracer for identifying sentinel lymph nodes in melanoma

Journal of Nuclear Medicine

Volumn 40, Issue 7, 1999, Pages 1143-1148

  Bedrosian, Isabelle ^a   Scheff, Alice M ^a   Mick, Rosemarie ^a   Callans, Linda S ^a   Bucky, Louis P ^a   Spitz, Francis R ^a   Helsabeck, Cynthia ^a   Elder, David E ^a   Alavi, Abass ^a   Fraker, Douglas F ^a   Czerniecki, Brian J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

99mTc human serum albumin; Melanoma; Sentinel node mapping

Indexed keywords

HUMAN SERUM ALBUMIN TC 99M; TECHNETIUM SULFUR COLLOID TC 99M; TRACER; DIAGNOSTIC AGENT; FUCHSINE; ISO SULFAN BLUE; ISO-SULFAN BLUE; MACROSALB TC 99M; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRADERMAL DRUG ADMINISTRATION; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; SKIN TUMOR; VITAL STAIN; BIOPSY; COMPARATIVE STUDY; LYMPH NODE; LYMPHADENECTOMY; MIDDLE AGED; PATHOLOGY; SCINTISCANNING;

BIOPSY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; RADIOPHARMACEUTICALS; ROSANILINE DYES; SKIN NEOPLASMS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 0032587783     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Slingluff CL, Seigler H. Melanoma. In: Sabiston DCI, ed. Textbook of Surgery: The Basis of Modern Surgical Practice. 15th ed. Philadelphia, PA: WB Saunders; 1996.
2. Veronesi U, Adamus J, Bandiera D, et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med. 1977;297:627-630.
3. Sim F, Taylor W, Ivins J, Pritchard D, Soule E. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer. 1978;41:948-956.
4. Morton D, Wen D, Wong J, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
5. Kramer EL, Sanger JJ. Lymphoscintigraphy in 1987: selected aspects. In: Freeman LM, Weissman HS, eds. Nuclear Medicine Annual 1987. New York, NY: Raven Press; 1987:233-267.
6. Alex J, Weaver D, Fairbank J, Rankin B, Krag D. Gamma-probe guided lymph node localization in malignant melanoma. Surg Oncol. 1993;2:303-308.
7. Albertini J, Cruse C, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg. 1996;223:217-224.
8. Pijpers R, Collet G, Meijer S, Hoekstra O. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med. 1995;22:1238-1241.
9. Kapteijn B, Nieweg O, Muller S, et al. Validation of gamma probe detection of the sentinel node in melanoma. J Nucl Med. 1997;38:362-366.
10. Krag D, Meijer S, Weaver D, et al. Minimal access surgery for staging of malignant melanoma. Arch Surg. 1995;130:654-658.
11. Clark WH Jr, Elder DE, Guerry D 4th, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989;81:1893-1904.
12. Halpern AC, Schuchter LM. Prognostic models in melanoma. Semin Oncol. 1997;24(suppl 4):52-57.
13. Morton D, Wen D, Cochran A. Management of early-stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy. Surg Oncol Clin North Am. 1992;1:247-259.
14. Reintgen D. More rational and conservative surgical strategies for malignant melanoma using lymphatic mapping and sentinel node biopsy techniques. Curr Opin Oncol. 1996;8:152-158.
15. Essner R. The role of lymphoscintigraphy and sentinel node mapping in assessing patient risk in melanoma. Semin Oncol. 1997;24(suppl 4):S8-S10.
16. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma metastases. Ann Surg. 1994;220:759-767.
17. Glass L, Messina J, Cruse W, et al. The use of intraoperative lymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatol Surg. 1996;22:715-720.
18. Nathanson SD, Anaya P, Karvelis KC, Eck L, Havstad S. Sentinel lymph node uptake of two different technetium labeled radiocolloids. Ann Surg Oncol. 1997;4:104-110.
19. Alazraki NP, Eshima D, Eshima LA, et al. Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancers. Semin Nucl Med. 1997;27:55-67.
20. Bergqvist L, Strand S-E, Persson BR. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Semin Nucl Med. 1983;8:9-19.
21. Vera DR, Wisner ER, Stadalnik RC. Sentinel node imaging via a nonparticulate receptor-binding radiotracer. J Nucl Med. 1997;38:530-535.
22. Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med. 1998;39:1185-1190.